Stock Price Quote

ANKUR DRUGS & PHARMA LTD.

NSE : NABSE : 531683ISIN CODE : INE238D01012Industry : Pharmaceuticals & DrugsHouse : Private
BSE3.930 (0 %)
PREV CLOSE ( ) 3.93
OPEN PRICE ( ) 3.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9225
TODAY'S LOW / HIGH ( )3.65 4.02
52 WK LOW / HIGH ( ) 3.654.02
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1995
Management Info
Purnandu Jain - Chairman Purnandu Jain - Managing Director
Registered Office

Address C-306, Crystal Plaza,Andheri Link Road,Andheri West,
Mumbai,
Maharashtra-400053

Phone 022- 40682300

Email srane@ankurdrugs.com

Website www.ankurdrugs.com

Registrars Details
Ajel Ltd.
(Formerly AJEL Infotech Ltd.), 106, MHADA Commercial Complex,2nd floor, Near Oshiwara Police Station,Jogeshwari (West),Mumbai
Listing : BSE, NSE, MCX

NEWS

01Apr Purnandu Jain submits disclosure
The Exchange has received the disclosure under Regulation 29(2) of SEBI..
27Aug Sebi imposes Rs 40 lakh penalty on Ank
Securities and Exchange Board of India (Sebi) has imposed a penalty of R..
18May Ankur Drugs and Pharma informs about B
Ankur Drugs and Pharma has informed that a meeting of the Board of Direc..
17Dec Ankur Drugs and Pharma informs change
Ankur Drugs and Pharma has informed that the company has decided to chan..
12Nov Ankur Drugs and Pharma informs about f
Ankur Drugs and Pharma has informed about the financial results for the..

Financials

in Millions
QTR Dec 12 ANNUAL 12
Net Profit-408.42-2215.74
Gross Profit -408.42 -1903.02
Operating Profit -102.19-554.96
Net Sales 361.191530.82

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  26643.70 (0.58%)
M.Cap ( in Cr)56616.00
Pfizer (BSE)
peergroup  4473.85 (1.59%)
M.Cap ( in Cr)20466.85
Glaxosmithkline Phar (BSE)
peergroup  2355.75 (2.80%)
M.Cap ( in Cr)39907.83
Concord Biotech (BSE)
peergroup  1494.85 (4.43%)
M.Cap ( in Cr)15638.55
Zydus Lifesciences (BSE)
peergroup  1104.45 (5.00%)
M.Cap ( in Cr)111133.51

Shareholding Pattern

NON-INSTITUTION 77.7%
PROMOTERS 5.9%
FI/BANKS/INSURANCE 4.75%
FII 11.64%
MUTUAL FUNDS/UTI 0.01%
GOVERNMENT 0%

About Ankur Drugs & Pharma Ltd.

Ankur Drugs & Pharma Ltd. was incorporated in the year 1995. Its today's share price is 3.93. Its current market capitalisation stands at Rs 7.6 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1523.71 Cr and Total Income of Rs.1690.34 Cr. The company's management includes S C Rane, Ramesh Batham, Dileep Shinde, Girraj Vijayvargiya, Purnandu Jain, Purnandu Jain.

It is listed on the BSE with a BSE Code of 531683 , NSE with an NSE Symbol of ANKURDRUGS and ISIN of INE238D01012. It's Registered office is at C-306, Crystal Plaza,Andheri Link Road,Andheri WestMumbai-400053, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are MG Vashi & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.